Is the government willing to infringe on drug patents to curb a public health crisis?
European countries have taken varied approaches to curtailing use of too-thin models—will the U.S. take action, too?
Zubik v. Burwell highlights thorny issues surrounding Obamacare’s contraceptive coverage requirement.
A French agency’s report on the Germanwings accident reassesses the balance between medical privacy and public safety.
A recent petition filed by government workers reveals the extent of a growing nuclear safety design problem.
Although agencies have made strides concerning values for mortality risk reductions, more research is needed on these values.
A proposed rule would cover certain gender transition services for military members.
FDA issues new guidelines to medical device manufacturers to mitigate cybersecurity concerns.
Proposed change to the city’s code would eliminate outdoor temperature as a determinant for heating.
The FDA requests information in possible first steps to regulate the term “natural” on food labels.
Researchers argue for reducing FDA involvement in medical device regulation.
Nicholas Bagley analyzes expanding executive power in the name of health care reform.